Castle Biosciences, Inc. · NASDAQ:CSTL

Oelschlager Kristen M sold 4,153 Castle Biosciences, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 5, 2026

On Oct 1, 2026, Oelschlager Kristen M (Chief Operating Officer) sold 4,153 Castle Biosciences, Inc. shares at an average US$35.95 for US$149K under a trading plan, leaving 13,356 shares. Filed Oct 5, 2026 (Form 4).

Sold
4,153 shares
Price
US$35.95 average (US$35.75 to US$36.38)
Value
US$149K
Holding after
13,356 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockOption exercise4,153US$3.3817,509Direct
Oct 1, 2026Common StockSale2,807US$35.7514,702Direct
Oct 1, 2026Common StockSale1,346US$36.3813,356Direct

Source

View original at SEC

Related